{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:56:54Z","timestamp":1789397814333,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["424252458"],"award-info":[{"award-number":["424252458"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2019_A162"],"award-info":[{"award-number":["2019_A162"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative medical research of the Medical Faculty, University of M\u00fcnster","award":["ME 12 19 14"],"award-info":[{"award-number":["ME 12 19 14"]}]},{"DOI":"10.13039\/501100004869","name":"Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extracellular vesicles (EVs) harbor a plethora of different biomolecules, which they can transport across cells. In cancer, tumor-derived EVs thereby support the creation of a favorable tumor microenvironment. So far, EV uptake and cargo delivery into target cells have been regarded as the main mechanisms for the pro-tumoral function of EVs. To test this hypothesis, we investigated the fate of the oncogenic transmembrane Wnt tyrosine kinase-like orphan receptor 1 and 2 (ROR1, ROR2) delivered via distinct EV subpopulations to breast cancer cells and aimed to unravel their impact on tumor progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      EVs were isolated by differential ultracentrifugation from cell culture supernatant as well as plasma samples from healthy individuals (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927) and breast cancer patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200941). EVs were thoroughly characterized by electron microscopy, nanoparticle tracking analysis, immunoblot, and flow cytometry. ROR transfer to target cells was observed using microscopy-based assays and biodistribution experiments were conducted in syngeneic mice. EV impact on cancer cell migration and invasion was tested in functional assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed that the supernatant of ROR-overexpressing cells was sufficient for transferring the receptors to ROR-negative cells. Analyzing the secretome of the ROR-overexpressing cells, we detected a high enrichment of ROR1\/2 on large and small EVs, but not on large oncosomes. Interestingly, the majority of ROR-positive EVs remained attached to the target cell surface after 24\u00a0h of stimulation and was quickly removed by treatment with trypsin. Nonetheless, ROR-positive EVs increased migration and invasion of breast cancer cells, even after chemically inhibiting EV uptake, in dependence of RhoA downstream signaling. In vivo, ROR-depleted EVs tended to distribute less into organs prone for the formation of breast cancer metastases. ROR-positive EVs were also significantly elevated in the plasma of breast cancer patients and allowed to separate them from healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The oncogenic Wnt receptors ROR1\/2 are transferred via EVs to the surface of ROR-negative cancer cells, in which they induce an aggressive phenotype supporting tumor progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-023-01186-1","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T02:02:14Z","timestamp":1688954534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression"],"prefix":"10.1186","volume":"21","author":[{"given":"Barnabas","family":"Irmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janes","family":"Efing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea Elisabeth","family":"Reitnauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allegra","family":"Angenendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Heinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Tio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Gerwing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalen","family":"Bleckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Menck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"1186_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1186_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","volume":"19","author":"X Xu","year":"2020","unstructured":"Xu X, Zhang M, Xu F, Jiang S. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. Mol Cancer. 2020;19:165.","journal-title":"Mol Cancer"},{"key":"1186_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/cells10010142","volume":"10","author":"K Menck","year":"2021","unstructured":"Menck K, Heinrichs S, Baden C, Bleckmann A. The WNT\/ROR pathway in cancer: from signaling to therapeutic intervention. Cells. 2021;10:142 Multidisciplinary Digital Publishing Institute.","journal-title":"Cells"},{"key":"1186_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/carcin\/bgq269","volume":"32","author":"F Klemm","year":"2011","unstructured":"Klemm F, Bleckmann A, Siam L, Chuang HN, Rietk\u00f6tter E, Behme D, et al. \u03b2-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis. 2011;32:434\u201342.","journal-title":"Carcinogenesis"},{"key":"1186_CR5","doi-asserted-by":"publisher","first-page":"e31127","DOI":"10.1371\/journal.pone.0031127","volume":"7","author":"S Zhang","year":"2012","unstructured":"Zhang S, Chen L, Cui B, Chuang H-Y, Yu J, Wang-Rodriguez J, et al. ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth. PLoS ONE. 2012;7:e31127.","journal-title":"PLoS ONE"},{"key":"1186_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s13046-021-02187-z","volume":"40","author":"K Menck","year":"2021","unstructured":"Menck K, Heinrichs S, Wlochowitz D, Sitte M, Noeding H, Janshoff A, et al. WNT11\/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer. J Exp Clin Cancer Res. 2021;40:395.","journal-title":"J Exp Clin Cancer Res"},{"key":"1186_CR7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/ncb2574","volume":"14","author":"JC Gross","year":"2012","unstructured":"Gross JC, Chaudhary V, Bartscherer K, Boutros M. Active Wnt proteins are secreted on exosomes. Nat Cell Biol Nature Publishing Group. 2012;14:1036\u201345.","journal-title":"Nat Cell Biol Nature Publishing Group"},{"key":"1186_CR8","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.18632\/oncotarget.1336","volume":"4","author":"K Menck","year":"2013","unstructured":"Menck K, Klemm F, Gross JC, Pukrop T, Wenzel D, Binder C. Induction and transport of Wnt 5a during macrophage-induced malignant invasion is mediated by two types of extracellular vesicles. Oncotarget. 2013;4:2057\u201366.","journal-title":"Oncotarget"},{"key":"1186_CR9","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, Siljander PR-M, Andreu Z, Zavec AB, Borr\u00e0s FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.","journal-title":"J Extracell Vesicles"},{"key":"1186_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/ijms17020175","volume":"17","author":"C Ciardiello","year":"2016","unstructured":"Ciardiello C, Cavallini L, Spinelli C, Yang J, Reis-Sobreiro M, de Candia P, et al. Focus on extracellular vesicles: new frontiers of cell-to-cell communication in cancer. Int J Mol Sci. 2016;17:175.","journal-title":"Int J Mol Sci"},{"key":"1186_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado H, Ale\u010dkovi\u0107 M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18:883\u201391.","journal-title":"Nat Med"},{"key":"1186_CR12","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816\u201326.","journal-title":"Nat Cell Biol"},{"key":"1186_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.semcancer.2022.01.003","volume":"86","author":"T Eguchi","year":"2022","unstructured":"Eguchi T, Sheta M, Fujii M, Calderwood SK. Cancer extracellular vesicles, tumoroid models, and tumor microenvironment. Semin Cancer Biol. 2022;86:112\u201326.","journal-title":"Semin Cancer Biol"},{"key":"1186_CR14","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.4161\/onci.20897","volume":"1","author":"S Munich","year":"2012","unstructured":"Munich S, Sobo-Vujanovic A, Buchser WJ, Beer-Stolz D, Vujanovic NL. Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. Oncoimmunology. 2012;1:1074\u201383.","journal-title":"Oncoimmunology"},{"key":"1186_CR15","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.15252\/embj.201696003","volume":"36","author":"M Tkach","year":"2017","unstructured":"Tkach M, Kowal J, Zucchetti AE, Enserink L, Jouve M, Lankar D, et al. Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes. EMBO J. 2017;36:3012\u201328.","journal-title":"EMBO J"},{"key":"1186_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00002030-200301030-00006","volume":"17","author":"T Rozmyslowicz","year":"2003","unstructured":"Rozmyslowicz T, Majka M, Kijowski J, Murphy SL, Conover DO, Poncz M, et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS. 2003;17:33.","journal-title":"AIDS"},{"key":"1186_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/sj.leu.2404132","volume":"20","author":"J Ratajczak","year":"2006","unstructured":"Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006;20:847\u201356 Nature Publishing Group.","journal-title":"Leukemia"},{"key":"1186_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ncb1725","volume":"10","author":"K Al-Nedawi","year":"2008","unstructured":"Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008;10:619\u201324 Nature Publishing Group.","journal-title":"Nat Cell Biol"},{"key":"1186_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Communication and Signaling. 2021;19:47.","journal-title":"Cell Communication and Signaling"},{"key":"1186_CR20","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8:2281\u2013308.","journal-title":"Nat Protoc"},{"key":"1186_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nmeth.4185","volume":"14","author":"J Van Deun","year":"2017","unstructured":"Van Deun J, Mestdagh P, Agostinis P, Akay \u00d6, Anand S, Anckaert J, et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017;14:228\u201332 Nature Publishing Group.","journal-title":"Nat Methods"},{"key":"1186_CR22","doi-asserted-by":"publisher","first-page":"1340745","DOI":"10.1080\/20013078.2017.1340745","volume":"6","author":"K Menck","year":"2017","unstructured":"Menck K, Bleckmann A, Wachter A, Hennies B, Ries L, Schulz M, et al. Characterisation of tumour-derived microvesicles in cancer patients\u2019 blood and correlation with clinical outcome. J Extracell Vesicles. 2017;6:1340745.","journal-title":"J Extracell Vesicles"},{"key":"1186_CR23","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s11307-020-01521-9","volume":"22","author":"M Gerwing","year":"2020","unstructured":"Gerwing M, Kocman V, St\u00f6lting M, Helfen A, Masthoff M, Roth J, et al. Tracking of tumor cell-derived extracellular vesicles in vivo reveals a specific distribution pattern with consecutive biological effects on target sites of metastasis. Mol Imaging Biol. 2020;22:1501 Springer.","journal-title":"Mol Imaging Biol"},{"key":"1186_CR24","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1073\/pnas.0509703103","volume":"103","author":"T Pukrop","year":"2006","unstructured":"Pukrop T, Klemm F, Hagemann T, Gradl D, Schulz M, Siemes S, et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A. 2006;103:5454\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1186_CR25","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1158\/2159-8290.CD-13-0005","volume":"3","author":"MP O\u2019Connell","year":"2013","unstructured":"O\u2019Connell MP, Marchbank K, Webster MR, Valiga AA, Kaur A, Vultur A, et al. Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. Cancer Discov. 2013;3:1378\u201393.","journal-title":"Cancer Discov"},{"key":"1186_CR26","doi-asserted-by":"publisher","first-page":"E968","DOI":"10.1073\/pnas.1521230113","volume":"113","author":"J Kowal","year":"2016","unstructured":"Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113:E968-77.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1186_CR27","doi-asserted-by":"publisher","first-page":"11327","DOI":"10.18632\/oncotarget.3598","volume":"6","author":"VR Minciacchi","year":"2015","unstructured":"Minciacchi VR, You S, Spinelli C, Morley S, Zandian M, Aspuria P-J, et al. Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles. Oncotarget. 2015;6:11327\u201341.","journal-title":"Oncotarget"},{"key":"1186_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-016-9780-3","volume":"33","author":"A Bleckmann","year":"2016","unstructured":"Bleckmann A, Conradi L-C, Menck K, Schmick NA, Schubert A, Rietk\u00f6tter E, et al. \u03b2-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases. Clin Exp Metastasis. 2016;33:309\u201323.","journal-title":"Clin Exp Metastasis"},{"key":"1186_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/jmcb\/mju047","volume":"7","author":"K Menck","year":"2015","unstructured":"Menck K, Scharf C, Bleckmann A, Dyck L, Rost U, Wenzel D, et al. Tumor-derived microvesicles mediate human breast cancer invasion through differentially glycosylated EMMPRIN. J Mol Cell Biol. 2015;7:143\u201353.","journal-title":"J Mol Cell Biol"},{"key":"1186_CR30","doi-asserted-by":"publisher","first-page":"10522","DOI":"10.1038\/s41598-019-47023-9","volume":"9","author":"V Toribio","year":"2019","unstructured":"Toribio V, Morales S, L\u00f3pez-Mart\u00edn S, Carde\u00f1es B, Caba\u00f1as C, Y\u00e1\u00f1ez-M\u00f3 M. Development of a quantitative method to measure EV uptake. Sci Rep. 2019;9:10522 Nature Publishing Group.","journal-title":"Sci Rep"},{"key":"1186_CR31","first-page":"Unit 20.2","volume":"Chapter 20","author":"BA Pulaski","year":"2001","unstructured":"Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol. 2001;Chapter 20:Unit 20.2.","journal-title":"Curr Protoc Immunol"},{"key":"1186_CR32","doi-asserted-by":"publisher","unstructured":"Wiklander OPB, Nordin JZ, O\u2019Loughlin A, Gustafsson Y, Corso G, M\u00e4ger I, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:https:\/\/doi.org\/10.3402\/jev.v4.26316.","DOI":"10.3402\/jev.v4.26316"},{"key":"1186_CR33","doi-asserted-by":"publisher","first-page":"e61539","DOI":"10.7554\/eLife.61539","volume":"10","author":"S Ghoroghi","year":"2021","unstructured":"Ghoroghi S, Mary B, Larnicol A, Asokan N, Klein A, Osmani N, et al. Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes. Pfeffer SR, Golemis EA, Hobbs A, editors. eLife. 2021;10:e61539 eLife Sciences Publications, Ltd.","journal-title":"eLife"},{"key":"1186_CR34","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/nm.2994","volume":"18","author":"H Shao","year":"2012","unstructured":"Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS, et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med. 2012;18:1835\u201340.","journal-title":"Nat Med"},{"key":"1186_CR35","doi-asserted-by":"publisher","first-page":"18704","DOI":"10.3402\/jev.v1i0.18704","volume":"1","author":"D-S Choi","year":"2012","unstructured":"Choi D-S, Choi D-Y, Hong B, Jang S, Kim D-K, Lee J, et al. Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells. J Extracell Vesicles. 2012;1:18704 Taylor & Francis.","journal-title":"J Extracell Vesicles"},{"key":"1186_CR36","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/cells8080777","volume":"8","author":"MP Scavo","year":"2019","unstructured":"Scavo MP, Depalo N, Rizzi F, Ingrosso C, Fanizza E, Chieti A, et al. FZD10 carried by exosomes sustains cancer cell proliferation. Cells. 2019;8:777 Multidisciplinary Digital Publishing Institute.","journal-title":"Cells"},{"key":"1186_CR37","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1038\/ncomms10060","volume":"7","author":"T Yamaguchi","year":"2016","unstructured":"Yamaguchi T, Lu C, Ida L, Yanagisawa K, Usukura J, Cheng J, et al. ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nat Commun. 2016;7:10060 Nature Publishing Group.","journal-title":"Nat Commun"},{"key":"1186_CR38","first-page":"46","volume":"8","author":"K Ni","year":"2020","unstructured":"Ni K, Wang C, Carnino JM, Jin Y. The evolving role of Caveolin-1: a critical regulator of extracellular vesicles. Med Sci. 2020;8:46 Multidisciplinary Digital Publishing Institute.","journal-title":"Med Sci"},{"key":"1186_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/biom8030094","volume":"8","author":"H Pollet","year":"2018","unstructured":"Pollet H, Conrard L, Cloos A-S, Tyteca D. Plasma membrane lipid domains as platforms for vesicle biogenesis and shedding? Biomolecules. 2018;8:94 Multidisciplinary Digital Publishing Institute.","journal-title":"Biomolecules"},{"key":"1186_CR40","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk A, Janiszewska M, Polyak K. Intratumor heterogeneity: the rosetta stone of therapy resistance. Cancer Cell. 2020;37:471\u201384.","journal-title":"Cancer Cell"},{"key":"1186_CR41","doi-asserted-by":"publisher","first-page":"e112614","DOI":"10.15252\/embj.2022112614","volume":"1","author":"M Yamazaki","year":"2023","unstructured":"Yamazaki M, Hino S, Usuki S, Miyazaki Y, Oda T, Nakao M, et al. YAP\/BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer. EMBO J. 2023;1:e112614 John Wiley & Sons, Ltd.","journal-title":"EMBO J"},{"key":"1186_CR42","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1073\/pnas.1816262116","volume":"116","author":"S Zhang","year":"2019","unstructured":"Zhang S, Zhang H, Ghia EM, Huang J, Wu L, Zhang J, et al. Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody. Proc Natl Acad Sci U S A. 2019;116:1370\u20137 Proceedings of the National Academy of Sciences.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1186_CR43","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1038\/onc.2017.206","volume":"36","author":"K Roarty","year":"2017","unstructured":"Roarty K, Pfefferle AD, Creighton CJ, Perou CM, Rosen JM. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression. Oncogene. 2017;36:5958\u201368.","journal-title":"Oncogene"},{"key":"1186_CR44","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1038\/s41467-022-31250-2","volume":"13","author":"F Xie","year":"2022","unstructured":"Xie F, Zhou X, Su P, Li H, Tu Y, Du J, et al. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-\u03b2 type II receptor signaling. Nat Commun. 2022;13:4461 Nature Publishing Group.","journal-title":"Nat Commun"},{"key":"1186_CR45","doi-asserted-by":"publisher","first-page":"110651","DOI":"10.1016\/j.celrep.2022.110651","volume":"39","author":"K O\u2019Brien","year":"2022","unstructured":"O\u2019Brien K, Ughetto S, Mahjoum S, Nair AV, Breakefield XO. Uptake, functionality, and re-release of extracellular vesicle-encapsulated cargo. Cell Rep. 2022;39:110651.","journal-title":"Cell Rep"},{"key":"1186_CR46","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1084\/jem.183.3.1161","volume":"183","author":"G Raposo","year":"1996","unstructured":"Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161\u201372.","journal-title":"J Exp Med"},{"key":"1186_CR47","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1172\/JCI83535","volume":"126","author":"J Yu","year":"2016","unstructured":"Yu J, Chen L, Cui B, Widhopf GF, Shen Z, Wu R, et al. Wnt5a induces ROR1\/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation. J Clin Invest. 2016;126:585\u201398.","journal-title":"J Clin Invest"},{"key":"1186_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Mark MT, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329\u201335.","journal-title":"Nature"},{"key":"1186_CR49","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1158\/0008-5472.CAN-12-3832","volume":"73","author":"B Cui","year":"2013","unstructured":"Cui B, Zhang S, Chen L, Yu J, Widhopf GF, Fecteau J-F, et al. Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis. Cancer Res. 2013;73:3649\u201360.","journal-title":"Cancer Res"},{"key":"1186_CR50","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1038\/onc.2011.636","volume":"31","author":"B Li","year":"2012","unstructured":"Li B, Antonyak MA, Zhang J, Cerione RA. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene. 2012;31:4740\u20139.","journal-title":"Oncogene"},{"key":"1186_CR51","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1476-4598-13-88","volume":"13","author":"EJ Ekstr\u00f6m","year":"2014","unstructured":"Ekstr\u00f6m EJ, Bergenfelz C, von B\u00fclow V, Serifler F, Carlemalm E, J\u00f6nsson G, et al. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol Cancer. 2014;13:88.","journal-title":"Mol Cancer"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01186-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-023-01186-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01186-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T03:05:06Z","timestamp":1688958306000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-023-01186-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1186"],"URL":"https:\/\/doi.org\/10.1186\/s12964-023-01186-1","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human samples were obtained after informed consent as approved by the local ethics committees of the Medical association Westfalen-Lippe (approval no. 2020\u2013172-b-S). All animal experiments in this study have been approved by the responsible authorities (reference of local government approval 81\u201302.04.2021.A397). All applicable institutional and\/or national guidelines for the care and use of animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}